Plain-English translation of NCT07277920 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying two tools that might help doctors catch melanoma earlier and more accurately. The first is a special imaging camera that lets doctors see skin cells in detail without cutting into the skin. The second is genetic testing that looks at the DNA inside cells to understand which lesions are dangerous and which are harmless. This study combines both approaches to see if they work better together.
Many patients have skin lesions removed unnecessarily because doctors cannot confidently tell the difference between harmless moles and early melanoma just by looking. This study aims to identify clearer warning signs—both visual and genetic—that would help doctors diagnose melanoma earlier and avoid removing benign lesions.
You likely qualify if…
You likely don't qualify if…
If you join, your skin lesion will be imaged with the special camera before or after your scheduled removal surgery. The tissue removed will then be tested for genetic mutations to identify molecular patterns. Your participation involves one or more visits related to your existing surgical plan—there are no extra procedures beyond what you are already having done. The study team will compare the imaging features and genetic results to improve their understanding of which lesions are dangerous.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Italy